Kymera Therapeutics Inc.

NASDAQ: KYMR
Share price (3/25/25): $31.82
Market cap (3/25/25): $2.067 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Chadwick Jeremy G

Jacobs Bruce N.

News Filter

Change in Directors, Officers or Compensation

Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

Announces Third Quarter 2024 Financial Results and Provides a Business Update

Announces Proposed Public Offering

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC